PMH11 PROBABILISTIC COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN THE TREATMENT OF SEVERE DEPRESSION IN THE UNITED KINGDOM
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)66081-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66081-0/fulltext
Title :
PMH11 PROBABILISTIC COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN THE TREATMENT OF SEVERE DEPRESSION IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66081-0&doi=10.1016/S1098-3015(10)66081-0
First page :
Section Title :
Open access? :
No
Section Order :
447